Caring Brands, Inc. (CABR) Income Statement

NASDAQ: CABRRevenue, profits, margins and EPS over 3 years.

CABR 2025 at a glance

Fiscal year ended December 31, 2025 · U.S. dollars
Revenue+806.5%
$4,215
2025 · hover or tap a bar for each year
2023: $20,4212024: $465 (−97.7%)2025: $4,215 (+806.5%)
20232025
Gross profit
$2,342
2025 · hover or tap a bar for each year
2023: −$98,4532024: −$1,6072025: $2,342
20232025
Operating income
−$5.9M
2025 · hover or tap a bar for each year
2023: −$151,3942024: −$1.5M2025: −$5.9M
20232025
Net income
−$6.3M
2025 · hover or tap a bar for each year
2023: −$128,0862024: −$1.5M2025: −$6.3M
20232025
EPS (diluted)
−$0.44
2025 · hover or tap a bar for each year
2024: −$0.052025: −$0.44
20232025
Net profit margin+177,380.5 pts
−148,948.8%
2025 · hover or tap a point for each year
2023: −627.2%2024: −326,329.2% (−325,702.0 pts)2025: −148,948.8% (+177,380.5 pts)
20232025

CABR revenue and net income

RevenueNet incomeNet margin (right axis)

Where CABR's revenue goes

2025
Revenue
$4,215100.0%
Cost of revenue
−$1,873−44.4%
Gross profit
$2,34255.6%
Sales, general & admin
−$3.1M−73,247.1%
Other operating expenses
−$2.9M−67,615.7%
Operating income
−$5.9M−140,807.2%
Interest & other expense
−$343,166−8,141.5%
Net income
−$6.3M−148,948.8%

Each bar shows an amount and its share of revenue. CABR kept −148,948.8% of revenue as net income.

CABR profit margins

GrossOperatingNet

CABR growth rates

to 2025
1 year3 years5 years10 years
Revenue+806.5%———
Gross profit————
Operating income————
Net income————
EPS (diluted)————

1-year change and average annual growth (CAGR) over 3, 5 and 10 fiscal years. "—" when a starting value was zero or negative.

CABR quarterly EPS vs estimates

Reported EPSAnalyst estimate

Caring Brands beat the analyst EPS estimate in 0 of the last 3 quarters. Next report: November 13, 2026.

CABR income statement

Caring Brands, Inc. annual income statement
202520242023
Revenue$4,215$465$20,421
Cost of revenue$1,873$2,072$118,874
Gross profit$2,342−$1,607−$98,453
Sales, general & admin$3.1M$721,214—
Total operating expenses$5.9M$1.5M$171,815
Operating income−$5.9M−$1.5M−$151,394
Interest expense$19,166——
Income before taxes−$6.3M−$1.5M−$128,086
Net income−$6.3M−$1.5M−$128,086
EBITDA−$5.3M−$1.4M−$149,194
EPS (diluted)−$0.44−$0.05—
Gross margin55.6%−345.6%−482.1%
Operating margin−140,807.2%−328,471.8%−741.4%
Net margin−148,948.8%−326,329.2%−627.2%

Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported in CABR's financial statements (latest annual report filed March 31, 2026); data from EODHD. Sales, general & administrative expenses include sales and marketing.

CABR financial results

In fiscal year 2025 (ended December 31, 2025), Caring Brands reported revenue of $0.0 million, up 806.5% from the year before. It had a net loss of $6.3 million, a net profit margin of −148,948.8%. Diluted earnings per share came to −$0.44.

See the CABR stock overview for the latest quote and news, or the CABR chart for price history and technical indicators.

CABR income statement FAQ

What is Caring Brands's annual revenue?

Caring Brands reported total revenue of $0.0 million for fiscal year 2025, which ended on December 31, 2025. That was up 806.5% from $0.0 million the previous year.

Is Caring Brands profitable?

No. Caring Brands reported a net loss of $6.3 million in fiscal 2025, a net profit margin of −148,948.8%; its operating margin was −140,807.2%.

What is Caring Brands's gross margin?

Caring Brands's gross margin was 55.6% in fiscal 2025: for every $100 of revenue, Caring Brands kept $56 after the direct cost of its products and services.

What are Caring Brands's earnings per share?

Caring Brands earned $-0.44 per diluted share in fiscal 2025, compared with $-0.05 a year earlier.

When will Caring Brands report its next earnings?

Caring Brands is expected to report results for the quarter ending September 30, 2026 on November 13, 2026.

When does Caring Brands's fiscal year end?

Caring Brands's fiscal year ends in December. The latest annual report covers the year ended December 31, 2025 and was filed on March 31, 2026.

Drug Manufacturers - Specialty & Generic income statements